<DOC>
	<DOCNO>NCT01818869</DOCNO>
	<brief_summary>This study investigate safety , tolerability , pharmacokinetics pharmacodynamics multiple ascend dos AZD8848 healthy subject .</brief_summary>
	<brief_title>To Assess Safety , Tolerability , Pharmacokinetics Pharmacodynamics Multiple Doses AZD8848 Healthy Subjects</brief_title>
	<detailed_description>A Phase 1 , Single Centre , Double-blind , Randomised , Placebo-controlled , Study Investigate Safety , Tolerability , Pharmacokinetics , Pharmacodynamics Administration Multiple Ascending ( MAD ) Once Weekly Inhaled Doses AZD8848 Healthy Subjects</detailed_description>
	<criteria>Healthy male and/or female subject age 18 50 year ( inclusive ) suitable vein cannulation repeat venipuncture Women must nonchildbearing potential must stable highly effective contraceptive least 3 month prior Screening willing continue choose contraceptive additonal use condom 3 month postdose Male subject willing use barrier contraception ie , condom , first day investigational product administration 3 month last administration investigational product Have body mass index ( BMI ) 18 32 kg/m2 weigh least 50 kg 110 kg Women must negative pregnancy test screen admission study centre , must date last menstruation , must lactate must nonchildbearing potential Abnormal vital sign , 10 minute supine rest , define follow : SBP &gt; 140 mmHg , Diastolic blood pressure ( DBP ) &gt; 90 mmHg , Heart rate &lt; 40 &gt; 85 beat per minute History asthma allergic rhinitis Prolonged QTcF &gt; 450 m shorten QTcF &lt; 340 m family history long QT syndrome History severe allergy/hypersensitivity ongoing allergy/hypersensitivity , judge Investigator history hypersensitivity drug similar chemical structure class AZD8848 Any clinically significant abnormality clinical chemistry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Safety ,</keyword>
	<keyword>tolerability ,</keyword>
	<keyword>Phase I ,</keyword>
	<keyword>pharmacokinetic ,</keyword>
	<keyword>pharmacodynamic ,</keyword>
	<keyword>inhale</keyword>
</DOC>